IAVI Report

IAVI Report is a scientific publication that provides comprehensive and editorially independent coverage of HIV vaccine and prevention research, as well as the quest to develop vaccines and other preventive technologies to address other global health priorities. It features the voices and opinions of those leading these efforts and provides an unparalleled analysis of the latest scientific and policy research.

To access archived issues of IAVI Report dating back to 1996, click here.

Subscribe below to receive IAVI Report right to your inbox.

Questions/comments? Email us at iavireport@iavi.org.

Filter by

  • Health area

  • Locations

  • Topic

  • Year

  • Journal

  • Clear all

IAVI Report

IAVI REPORT – VOL. 25, NO. 1, 2021

June 29, 2021

The last time I penned a letter in this publication, nearly a year ago, I closed by saying: “If science is our best hope, we are in good hands.” That certainly proved to be the case. There are now three authorized COVID-19 vaccines in the U.S., and seven that have received an Emergency Use Listing…

Read more

IAVI Report

The future of antibody-based HIV prevention

May 4, 2021

How will the results from recent trials set the course for future research?

Read more

IAVI Report

In the midst of a pandemic and preparing for the next

August 4, 2020

SARS-CoV-2 is the first Disease X. There will certainly be others. Will the world be better prepared for the next one?

Read more

IAVI Report

Finding a global solution for a global problem

August 4, 2020

An interview with Seth Berkley, chief executive officer of Gavi, the Vaccine Alliance

Read more

IAVI Report

Monoclonal antibodies and their potential role in combatting COVID-19

August 4, 2020

Numerous monoclonal antibodies are already in development for both treatment and prevention. There are many unanswered questions, but, if they work, antibodies may play a role in ending this pandemic and in responding to future viral outbreaks.

Read more

IAVI Report

The race is on

August 4, 2020

Scientists are applying decades of HIV research experience to the development of SARS-CoV-2 vaccines in the race to end the pandemic.

Read more

IAVI Report

IAVI REPORT – VOL. 24, NO. 1, 2020

August 4, 2020

When Bill Gates delivered a TED talk in 2015, he warned that the world was not ready for the next pandemic. Many others have issued similar warnings, some on the pages of this publication. Vanity Fair recently referred to Gates, Mike Osterholm, and Seth Berkley (see Finding a global solution for a global problem), among…

Read more

IAVI Report

Igniting passion for the long haul

December 16, 2019

Linda-Gail Bekker talks about how she came to work on HIV and shares her thoughts on an evolving field.

Read more

IAVI Report

An industry leader in HIV research

November 22, 2019

Paul Stoffels of Johnson & Johnson talks about the company’s broad HIV portfolio and the role of industry in advancing vaccine research.

Read more

IAVI Report

Coding for protection

November 22, 2019

Although challenges remain, the growing field of mRNA-based vaccine development seems to have a bright future, with potential for preventing cancer, flu, and HIV.

Read more

IAVI Report

Is there an HIV prevention crisis?

November 22, 2019

More HIV-infected people than ever before are receiving life-saving treatment. Despite this progress, HIV incidence rates remain virtually static.

Read more

IAVI Report

Upcoming efficacy trial illustrates the value of African-led science

November 22, 2019

We must continue to engage local investigators and develop their capacity to conduct more basic and clinical research on the African continent.

Read more